The co-administration of these two drugs at lower doses not only reduces blood pressure and improves microcirculation but also alleviates endothelial dysfunction by upregulating the expression of endothelial nitric oxide synthase (eNOS). Here, NOS3 is linked to endothelial dysfunction.